TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · IEX Real-Time Price · USD
4.40
+0.25 (6.02%)
At close:
Jun 2, 2023, 4:00 PM
4.11
-0.29 (-6.59%)
After-hours:
Jun 2, 2023, 6:10 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 69.96 | 2.57 | 64.87 | 49.65 | 16.1 | 16.78 | 19.36 | 20.14 | 15.03 | 8.78 | |
| Revenue Growth (YoY) | 2619.12% | -96.03% | 30.67% | 208.38% | -4.04% | -13.32% | -3.90% | 34.05% | 71.23% | 129.85% | |
| Cost of Revenue | 1.4 | 1.4 | 15.98 | 6.34 | 2.74 | 2.64 | 4.19 | 4.51 | 3.67 | 1.96 | |
| Gross Profit | 68.57 | 1.17 | 48.9 | 43.31 | 13.36 | 14.14 | 15.17 | 15.64 | 11.35 | 6.82 | |
| Selling, General & Admin | 57.9 | 80.75 | 194.01 | 174.73 | 115.99 | 57.7 | 51.35 | 28.72 | 22.12 | 19.01 | |
| Research & Development | 0 | 0 | 10.43 | 19.79 | 27.3 | 33.85 | 53.94 | 72.04 | 43.22 | 13.55 | |
| Other Operating Expenses | 9.47 | 0 | 0 | 0 | 0.29 | 0.21 | 0.13 | 0.06 | 0.05 | 0.06 | |
| Operating Expenses | 67.38 | 80.75 | 204.44 | 194.52 | 143.58 | 91.77 | 105.42 | 100.83 | 65.4 | 32.62 | |
| Operating Income | 1.19 | -79.58 | -155.54 | -151.21 | -130.22 | -77.63 | -90.25 | -85.19 | -54.04 | -25.81 | |
| Interest Expense / Income | 0 | 0 | 28.58 | 17.38 | 4.68 | 0 | 0 | 0 | 0 | 1.17 | |
| Other Expense / Income | -110.81 | 92.84 | -0.6 | 7.56 | -2.28 | -0.7 | -0.38 | -0.11 | 0.18 | 1.45 | |
| Pretax Income | 112 | -172.42 | -183.52 | -176.15 | -132.62 | -76.93 | -89.88 | -85.08 | -54.22 | -28.42 | |
| Net Income | 112 | -172.42 | -183.52 | -176.15 | -132.62 | -76.93 | -89.88 | -85.08 | -54.22 | -28.42 | |
| Shares Outstanding (Basic) | 9 | 8 | 6 | 5 | 5 | 4 | 4 | 3 | 3 | 3 | |
| Shares Outstanding (Diluted) | 9 | 8 | 6 | 5 | 5 | 4 | 4 | 3 | 3 | 3 | |
| Shares Change | 17.66% | 44.39% | 11.89% | 9.48% | 9.49% | 4.81% | 13.23% | 15.66% | 17.37% | 39.22% | |
| EPS (Basic) | 12.41 | -21.66 | -33.50 | -36.00 | -29.50 | -18.50 | -23.00 | -24.50 | -18.00 | -11.00 | |
| EPS (Diluted) | 11.96 | -21.66 | -33.50 | -36.00 | -29.50 | -18.50 | -23.00 | -24.50 | -18.00 | -11.00 | |
| Free Cash Flow Per Share | -0.45 | -17.93 | -28.96 | -34.13 | -23.78 | -18.54 | -17.73 | -22.87 | -15.21 | -8.16 | |
| Gross Margin | 98.00% | 45.51% | 75.37% | 87.24% | 83.00% | 84.28% | 78.38% | 77.63% | 75.56% | 77.67% | |
| Operating Margin | 1.70% | -3092.77% | -239.77% | -304.56% | -808.85% | -462.69% | -466.27% | -422.93% | -359.65% | -294.09% | |
| Profit Margin | 160.08% | -6700.93% | -282.90% | -354.79% | -823.74% | -458.50% | -464.32% | -422.37% | -360.82% | -323.84% | |
| Free Cash Flow Margin | -5.83% | -5547.10% | -246.14% | -338.73% | -664.80% | -454.28% | -359.25% | -393.24% | -303.15% | -237.12% | |
| EBITDA | 113.19 | -171.68 | -150.88 | -157.37 | -127.65 | -76.71 | -89.74 | -85.01 | -54.16 | -27.2 | |
| EBITDA Margin | 161.79% | -6672.33% | -232.57% | -316.98% | -792.86% | -457.23% | -463.63% | -422.06% | -360.47% | -309.90% | |
| Depreciation & Amortization | 1.19 | 0.74 | 4.07 | 1.39 | 0.29 | 0.21 | 0.13 | 0.06 | 0.05 | 0.06 | |
| EBIT | 112 | -172.42 | -154.94 | -158.76 | -127.94 | -76.93 | -89.88 | -85.08 | -54.22 | -27.25 | |
| EBIT Margin | 160.08% | -6700.93% | -238.84% | -319.78% | -794.68% | -458.50% | -464.32% | -422.37% | -360.82% | -310.56% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).